A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (gamma delta) T Cells in Adults with B-Cell Malignancies Neelapu, S. S., Stevens, D. A., Hamadani, M., Frank, M. J., Holmes, H., Jacobovits, A., Hinkle, J., Kennedy-Wilde, J., Maller, O., Weinstein, B., Galimi, F., Lai, R. K., Miklos, D. B. AMER SOC HEMATOLOGY. 2022: 4617-4619

View details for DOI 10.1182/blood-2022-157400

View details for Web of Science ID 000893223204283